Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-03

AUTHORS

Horng H. Chen, Alessandro Cataliotti, John C. Burnett

ABSTRACT

Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system. More... »

PAGES

s15-s21

References to SciGraph publications

  • <error retrieving object. in <ERROR RETRIEVING OBJECT
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y

    DOI

    http://dx.doi.org/10.1007/s11906-001-0102-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1053694779

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/11716801


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin-Converting Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Atrial Natriuretic Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cardiovascular Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Heart Failure", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kidney", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neprilysin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pyridines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Thiazepines", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chen", 
            "givenName": "Horng H.", 
            "id": "sg:person.01024326700.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cataliotti", 
            "givenName": "Alessandro", 
            "id": "sg:person.015220345407.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015220345407.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
              "id": "http://www.grid.ac/institutes/grid.66875.3a", 
              "name": [
                "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Burnett", 
            "givenName": "John C.", 
            "id": "sg:person.01001266776.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s11886-000-0069-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026762752", 
              "https://doi.org/10.1007/s11886-000-0069-3"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-03", 
        "datePublishedReg": "2001-03-01", 
        "description": "Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11906-001-0102-y", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2384951", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2532198", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1021183", 
            "issn": [
              "1522-6417", 
              "1534-3111"
            ], 
            "name": "Current Hypertension Reports", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "Suppl 2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "3"
          }
        ], 
        "keywords": [
          "natriuretic peptide system", 
          "angiotensin-converting enzyme", 
          "humoral actions", 
          "heart failure", 
          "natriuretic peptide", 
          "ACE inhibition", 
          "natriuretic peptide receptor antagonist", 
          "mild heart failure", 
          "peptide receptor antagonist", 
          "experimental heart failure", 
          "peptide system", 
          "new pharmacologic agents", 
          "mechanism of action", 
          "renal actions", 
          "vasopeptidase inhibitor", 
          "receptor antagonist", 
          "pharmacologic agents", 
          "omapatrilat", 
          "Recent studies", 
          "novel molecules", 
          "inhibition", 
          "failure", 
          "antagonist", 
          "peptides", 
          "action", 
          "inhibitors", 
          "study", 
          "role", 
          "agents", 
          "absence", 
          "enzyme", 
          "presence", 
          "mechanism", 
          "biology", 
          "insights", 
          "investigation", 
          "molecules", 
          "system"
        ], 
        "name": "Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure", 
        "pagination": "s15-s21", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1053694779"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11906-001-0102-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "11716801"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11906-001-0102-y", 
          "https://app.dimensions.ai/details/publication/pub.1053694779"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:21", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_345.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11906-001-0102-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    162 TRIPLES      22 PREDICATES      76 URIs      67 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11906-001-0102-y schema:about N47bea9fa99114fa9bbe85ea12fb8f763
    2 N539fa19827e84be69c2b195f66382a88
    3 N64f9c23ba1554b36a8c4e8d4edc4dc8b
    4 N7639b7df35684c789525521888f73c82
    5 N99d77d010c214e0aac5931bc32401122
    6 Nbfa6c0a3ca9f4c69831f03e0c0c17141
    7 Nd766183782d34e539940e3f13c1c476b
    8 Ne6ea52b5f7d54b33af2a020f9d209b6f
    9 Ne6f50565cd934d8297f87e5d374cab83
    10 Ne704711b1fe4443baeec6bd1f4096aeb
    11 anzsrc-for:11
    12 anzsrc-for:1102
    13 schema:author N0d29c4dbfab3467099014033345c8531
    14 schema:citation sg:pub.10.1007/s11886-000-0069-3
    15 schema:datePublished 2001-03
    16 schema:datePublishedReg 2001-03-01
    17 schema:description Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system.
    18 schema:genre article
    19 schema:inLanguage en
    20 schema:isAccessibleForFree false
    21 schema:isPartOf N5f510d3907494d5996187db1e86a36d8
    22 N9694896ef73543a18539b77b981ac96c
    23 sg:journal.1021183
    24 schema:keywords ACE inhibition
    25 Recent studies
    26 absence
    27 action
    28 agents
    29 angiotensin-converting enzyme
    30 antagonist
    31 biology
    32 enzyme
    33 experimental heart failure
    34 failure
    35 heart failure
    36 humoral actions
    37 inhibition
    38 inhibitors
    39 insights
    40 investigation
    41 mechanism
    42 mechanism of action
    43 mild heart failure
    44 molecules
    45 natriuretic peptide
    46 natriuretic peptide receptor antagonist
    47 natriuretic peptide system
    48 new pharmacologic agents
    49 novel molecules
    50 omapatrilat
    51 peptide receptor antagonist
    52 peptide system
    53 peptides
    54 pharmacologic agents
    55 presence
    56 receptor antagonist
    57 renal actions
    58 role
    59 study
    60 system
    61 vasopeptidase inhibitor
    62 schema:name Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure
    63 schema:pagination s15-s21
    64 schema:productId N319a1c0fcd474d4eb2158bfd9476db58
    65 N908f27f06a5b466889e8bed7ca1dd3cf
    66 Nb213f1f10f5941028d650542da65961a
    67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053694779
    68 https://doi.org/10.1007/s11906-001-0102-y
    69 schema:sdDatePublished 2022-05-20T07:21
    70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    71 schema:sdPublisher N0e01a2e779014d25a0b909ea059f8e88
    72 schema:url https://doi.org/10.1007/s11906-001-0102-y
    73 sgo:license sg:explorer/license/
    74 sgo:sdDataset articles
    75 rdf:type schema:ScholarlyArticle
    76 N0d29c4dbfab3467099014033345c8531 rdf:first sg:person.01024326700.50
    77 rdf:rest Nb4ef77e4442641a28c956be5db54bba3
    78 N0e01a2e779014d25a0b909ea059f8e88 schema:name Springer Nature - SN SciGraph project
    79 rdf:type schema:Organization
    80 N1d3e3e7e45004e66bf76561a78895471 rdf:first sg:person.01001266776.01
    81 rdf:rest rdf:nil
    82 N319a1c0fcd474d4eb2158bfd9476db58 schema:name doi
    83 schema:value 10.1007/s11906-001-0102-y
    84 rdf:type schema:PropertyValue
    85 N47bea9fa99114fa9bbe85ea12fb8f763 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    86 schema:name Atrial Natriuretic Factor
    87 rdf:type schema:DefinedTerm
    88 N539fa19827e84be69c2b195f66382a88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    89 schema:name Angiotensin-Converting Enzyme Inhibitors
    90 rdf:type schema:DefinedTerm
    91 N5f510d3907494d5996187db1e86a36d8 schema:volumeNumber 3
    92 rdf:type schema:PublicationVolume
    93 N64f9c23ba1554b36a8c4e8d4edc4dc8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Neprilysin
    95 rdf:type schema:DefinedTerm
    96 N7639b7df35684c789525521888f73c82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Pyridines
    98 rdf:type schema:DefinedTerm
    99 N908f27f06a5b466889e8bed7ca1dd3cf schema:name dimensions_id
    100 schema:value pub.1053694779
    101 rdf:type schema:PropertyValue
    102 N9694896ef73543a18539b77b981ac96c schema:issueNumber Suppl 2
    103 rdf:type schema:PublicationIssue
    104 N99d77d010c214e0aac5931bc32401122 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Thiazepines
    106 rdf:type schema:DefinedTerm
    107 Nb213f1f10f5941028d650542da65961a schema:name pubmed_id
    108 schema:value 11716801
    109 rdf:type schema:PropertyValue
    110 Nb4ef77e4442641a28c956be5db54bba3 rdf:first sg:person.015220345407.74
    111 rdf:rest N1d3e3e7e45004e66bf76561a78895471
    112 Nbfa6c0a3ca9f4c69831f03e0c0c17141 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Humans
    114 rdf:type schema:DefinedTerm
    115 Nd766183782d34e539940e3f13c1c476b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Animals
    117 rdf:type schema:DefinedTerm
    118 Ne6ea52b5f7d54b33af2a020f9d209b6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Heart Failure
    120 rdf:type schema:DefinedTerm
    121 Ne6f50565cd934d8297f87e5d374cab83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Kidney
    123 rdf:type schema:DefinedTerm
    124 Ne704711b1fe4443baeec6bd1f4096aeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Cardiovascular Agents
    126 rdf:type schema:DefinedTerm
    127 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    128 schema:name Medical and Health Sciences
    129 rdf:type schema:DefinedTerm
    130 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    131 schema:name Cardiorespiratory Medicine and Haematology
    132 rdf:type schema:DefinedTerm
    133 sg:grant.2384951 http://pending.schema.org/fundedItem sg:pub.10.1007/s11906-001-0102-y
    134 rdf:type schema:MonetaryGrant
    135 sg:grant.2532198 http://pending.schema.org/fundedItem sg:pub.10.1007/s11906-001-0102-y
    136 rdf:type schema:MonetaryGrant
    137 sg:journal.1021183 schema:issn 1522-6417
    138 1534-3111
    139 schema:name Current Hypertension Reports
    140 schema:publisher Springer Nature
    141 rdf:type schema:Periodical
    142 sg:person.01001266776.01 schema:affiliation grid-institutes:grid.66875.3a
    143 schema:familyName Burnett
    144 schema:givenName John C.
    145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01
    146 rdf:type schema:Person
    147 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
    148 schema:familyName Chen
    149 schema:givenName Horng H.
    150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
    151 rdf:type schema:Person
    152 sg:person.015220345407.74 schema:affiliation grid-institutes:grid.66875.3a
    153 schema:familyName Cataliotti
    154 schema:givenName Alessandro
    155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015220345407.74
    156 rdf:type schema:Person
    157 sg:pub.10.1007/s11886-000-0069-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026762752
    158 https://doi.org/10.1007/s11886-000-0069-3
    159 rdf:type schema:CreativeWork
    160 grid-institutes:grid.66875.3a schema:alternateName Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA
    161 schema:name Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA
    162 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...